stoxline Quote Chart Rank Option Currency Glossary
Nemaura Medical Inc. (NMRD)
0.08405  0.004 (5.33%)    04-19 15:56
Open: 0.073
High: 0.09
Volume: 11,913
Pre. Close: 0.0798
Low: 0.073
Market Cap: 2(M)
Technical analysis
2024-04-19 5:11:13 PM
Short term     
Mid term     
Targets 6-month :  0.1 1-year :  0.12
Resists First :  0.09 Second :  0.1
Pivot price 0.08
Supports First :  0.07 Second :  0.05
MAs MA(5) :  0.08 MA(20) :  0.08
MA(100) :  0.11 MA(250) :  0.39
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  54.5 D(3) :  47.1
RSI RSI(14): 50.1
52-week High :  1.25 Low :  0.06
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ NMRD ] has closed below upper band by 49.4%. Bollinger Bands are 49.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 60 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.09 - 0.09 0.09 - 0.09
Low: 0.07 - 0.07 0.07 - 0.07
Close: 0.08 - 0.08 0.08 - 0.08
Company Description

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Headline News

Wed, 10 Apr 2024
Nemaura Medical Restructures Finances, Board Members Change - - TipRanks

Wed, 03 Jan 2024
Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher - Esperion Therapeutics (NASDAQ:ESPR), Nemau - Benzinga

Wed, 13 Dec 2023
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision - Yahoo Finance

Mon, 04 Dec 2023
“Buzz on the Street” Show: Nemaura Medical (NASDAQ: NMRD) Update on Nasdaq Compliance Status | FINANCIAL ... -

Tue, 21 Nov 2023
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth - Yahoo Finance

Mon, 13 Nov 2023
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 29 (M)
Shares Float 15 (M)
Held by Insiders 48.6 (%)
Held by Institutions 4.4 (%)
Shares Short 53 (K)
Shares Short P.Month 192 (K)
Stock Financials
EPS -0.39
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.63
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -81.2 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.4
Qtrly Earnings Growth 0 %
Operating Cash Flow -10 (M)
Levered Free Cash Flow -10 (M)
Stock Valuations
PE Ratio -0.22
PEG Ratio 0
Price to Book value -0.14
Price to Sales 0
Price to Cash Flow -0.26
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android